Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Blogs

The contract manufacturing market for live biotherapeutics and microbiome growing at a CAGR of 46%, <Roots Analysis >

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage

Contract manufacturing market for live biotherapeutics and microbiome products

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone   London   Roots Analysis has announced the addition of “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 202

‘Blood-Brain Barrier (BBB) Market, 2020-2030’ <Roots Analysis>

To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html   Key Inclusions §  An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters, such as status of development (developed and under development), affiliated approach, type of compatible pharmacological molecule(s) crossing the BBB (sma

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.   To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this - https://www.rootsanalysis.com/repor

BBB penetrating drugs market is projected to grow at an annualized rate of ~154% <till 2030>

Roots Analysis has done a detailed study on Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html

Blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030 <Roots Analysis>

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries   Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

“Medical Device Labels Manufacturing Market, 2019-2030” <Roots Analysis>

To order this detailed 300+ page report, please visit this- https://www.rootsanalysis.com/reports/view_document/medical-device-labels-manufacturing-market-2019-2030/272.html   Key Inclusions §  A detailed review of the overall landscape of companies offering manufacturing services for medical device labels, along with information on location of headquarters, year of establishment, company size, details related to regulatory certification / accreditation, types of label printing te

More than 80 companies presently claim to have the required expertise to design and manufacture <Roots Analysis>

Owing to the ever-increasing number of medical devices along with the rising associated complexities and stringent guidelines issued by various regulatory authorities, the global medical device labeling market is likely to grow at stable rate. Furthermore, it is also necessary for the organizations to adopt labeling practices which can help them to reduce reaction time in order to process change requirements. Therefore, in order to overcome the aforementioned challenges, medical devices companie

Medical device label contract manufacturing market is projected to grow at an annualized rate of ~9.8% <till 2030>

Roots Analysis has done a detailed study on “Medical Device Labels Technology Market, 2019-2030 covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 300+ page report, which features 150+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-labels-manufacturing-market-2019-2030/272.html Key Market Insights      More than 80 companies presently claim to have the

Medical device label contract manufacturing market is projected to reach USD 509 million in 2030, <Roots Analysis>

Outsourcing the manufacturing of labels is a popular trend among medical device developers, enabling such companies to leverage the advanced capabilities of CMOs, while focusing on the core aspects of product development   Roots Analysis has announced the addition of “Medical Device Labels Technology Market, 2019-2030” report to its list of offerings.   The report features an extensive study of the current market landscape of companies offering manufacturing services for med

‘Human Microbiome Market: Focus on Therapeutics 2019-2030’ <Roots Analysis>

To order this detailed 640+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html   Key Inclusions §  A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, location of headquarters and company size), clinical study sponsor(s) or collaborators, phase of development (clinical, preclinical, and discovery stage

Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in

Human Microbiome-based Products Market is projected <claims Roots Analysis>

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings.   To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html   Key Market Insights §  Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease ind

Human Microbiome-based Products Market growing at an annualized rate of over 40% <Roots Analysis>

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic   Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings   The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the stu

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030 <Roots Analysis >

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future   Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings.   The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defin

“Global Handheld Ultrasound Imaging Devices Market, 2020-2030” <Roots Analysis>

To order this detailed 235+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html   Key Inclusions §  An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status of development, application area (abdomen, cardiac, gynecological, pulmonary, urological scanning and others), weight of device, type of transducer array (convex / curved, linear, micro-convex,

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).   To order this 235+ page report, which features 9

Global handheld ultrasound imaging devices market <Roots Analysis>

Roots Analysis has done a detailed study on “Global Handheld Ultrasound Imaging Devices Market, 2020-2030”” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html   Key Market Insights §  Several players are currently engaged in the developm

Global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030 <Roots Analysis>

Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the unmet need in this domain. In fact, the demand for handheld ultrasound devices is on a surge amidst the COVID-19 pandemic. These portable, pocket-friendly, point-of-care devices have revolutionized the treatment of COVID-19 patients by provide remote access to doctors and ensures

‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ <Roots Analysis>

To order this detailed 600+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html   Key Inclusions §  A detailed assessment of the current market landscape of ADCs, providing information on drug developer(s) and technology provider(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target antigen, type of linker, type of payload / warhead /

Presently, over 240 ADC therapy candidates are being evaluated in clinical <Roots Analysis>

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease associated cells / pathogens, with substantially lower risk of treatment related side effects.   To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this -

Antibody drug conjugates market is projected to grow at an annualized rate of over 20% <till 2030>

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market (5th Edition), 2019-2030.” , covering various important aspects of the industry and identifying key future growth opportunities.   To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html   Key Market Insights §  Eminent representatives from

Antibody drug conjugates market is estimated to be worth more than 15 billion in 2030 <Roots Analysis>

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community   Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”   The report features an extensive study of the current market landscape, offering an informed op
×
  • Create New...